TWD 32.85
(-18.69%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 4.85 Million TWD | 798.15% |
2022 | 540 Thousand TWD | -14.29% |
2021 | 630 Thousand TWD | 0.0% |
2020 | - TWD | 0.0% |
2019 | - TWD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | 263.5 Thousand TWD | 498.86% |
2024 Q2 | 263.5 Thousand TWD | 0.0% |
2023 Q3 | 44 Thousand TWD | -98.15% |
2023 FY | 4.85 Million TWD | 798.15% |
2023 Q1 | 2.38 Million TWD | 0.0% |
2023 Q4 | 44 Thousand TWD | 0.0% |
2023 Q2 | 2.38 Million TWD | 0.0% |
2022 Q3 | - TWD | 0.0% |
2022 FY | 540 Thousand TWD | -14.29% |
2022 Q4 | - TWD | 0.0% |
2021 FY | 630 Thousand TWD | 0.0% |
2020 FY | - TWD | 0.0% |
2019 FY | - TWD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Anti-Microbial Savior BioteQ Co., Ltd | 728 Thousand TWD | -566.209% |
SYN-TECH Chem. & Pharm. Co., Ltd. | 1.11 Billion TWD | 99.565% |
Level Biotechnology Inc. | 660.61 Million TWD | 99.266% |
Sagittarius Life Science Corp | 440.46 Million TWD | 98.899% |
NeoCore Technology Co., Ltd. | 64.72 Million TWD | 92.507% |
TaiMed Biologics Inc. | 491.77 Million TWD | 99.014% |
GlycoNex Incorporation | 2.54 Million TWD | -90.795% |
VBI | 55.85 Million TWD | 91.316% |
GeneReach Biotechnology Corp. | 225.46 Million TWD | 97.849% |
Taiwan Advance Bio-Pharmaceutical Inc. | 315.98 Million TWD | 98.465% |
SynCore Biotechnology Co.,Ltd | 20.19 Million TWD | 75.985% |
Genomics BioSci & Tech. Co.,Ltd. | 396.14 Million TWD | 98.776% |
Visgeneer Inc. | 147.99 Million TWD | 96.723% |
Mycenax Biotech Inc. | 652.62 Million TWD | 99.257% |
Sunmax Biotechnology Co., Ltd. | 1.68 Billion TWD | 99.713% |
G&E Herbal Biotechnology Co., Ltd. | 181.44 Million TWD | 97.327% |
Neith Corporation | 39.9 Million TWD | 87.846% |
Medigen Vaccine Biologics Corporation | 389.62 Million TWD | 98.755% |
TaiwanJ Pharmaceuticals Co., Ltd. | 22.74 Million TWD | 78.674% |
Enimmune corporation | 43.49 Million TWD | 88.849% |
TaiRx, Inc. | 5.08 Million TWD | 4.565% |
CHO Pharma, Inc. | - TWD | -Infinity% |
EirGenix Inc. | 1.02 Billion TWD | 99.526% |
BioLASCO Taiwan Co., Ltd. | 264.72 Million TWD | 98.168% |
Sunny Pharmtech Inc. | 428.82 Million TWD | 98.869% |
Lin BioScience, Inc. | - TWD | -Infinity% |
BioGend Therapeutics Co., Ltd. | 109.9 Million TWD | 95.587% |
Feng Chi Biotech Corp. | 180.57 Million TWD | 97.314% |
Bio Preventive Medicine Corp. | 1.2 Million TWD | -301.49% |
Lukas Biomedical Inc. | 231.83 Million TWD | 97.908% |
RBC Bioscience Corporation | 172.46 Million TWD | 97.188% |
BiOptic Inc. | 228.26 Million TWD | 97.875% |
BRIM Biotechnology, Inc. | 90 Thousand TWD | -5288.889% |
Shine-On BioMedical Co.,Ltd. | 9.52 Million TWD | 49.076% |
Syngen Biotech Co.,Ltd. | 1.83 Billion TWD | 99.736% |
Advagene Biopharma Co., Ltd. | - TWD | -Infinity% |
NaviFUS Corp. | 22.48 Million TWD | 78.426% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 141.17 Million TWD | 96.565% |
Sinew Pharma Inc. | - TWD | -Infinity% |
Andros Pharmaceuticals Co.,Ltd | 805 Thousand TWD | -502.484% |
Greenyn Biotechnology Co., Ltd | 800.51 Million TWD | 99.394% |
Lumosa Therapeutics Co., Ltd. | 56.91 Million TWD | 91.479% |
AP Biosciences Inc | 32.25 Million TWD | 84.963% |
Medigen Biotechnology Corp. | 1.15 Billion TWD | 99.581% |
3D Global Biotech Inc. | 20.63 Million TWD | 76.494% |
Pharmosa Biopharm Inc. | 314.5 Million TWD | 98.458% |
Intech Biopharm Corporation | 25.84 Million TWD | 81.236% |
Oneness Biotech Co., Ltd. | 86.78 Million TWD | 94.411% |
Eusol Biotech Co.,Ltd. | - TWD | -Infinity% |
TWi Biotechnology, Inc. | - TWD | -Infinity% |
Ever Supreme Bio Technology Co., Ltd | 758.39 Million TWD | 99.36% |
TCI GENE Inc. | 333.85 Million TWD | 98.547% |
MegaPro Biomedical Co., Ltd | 18 Thousand TWD | -26844.444% |
Senhwa Biosciences, Inc. | 1 Million TWD | -385.0% |
Taiwan Bio Therapeutics Co., Ltd | 85.47 Million TWD | 94.325% |
NatureWise Biotech & Medicals Corporation | 160.14 Million TWD | 96.971% |
PharmaEngine, Inc. | 767.66 Million TWD | 99.368% |
Savior Lifetec Corporation | 1.05 Billion TWD | 99.538% |
TaiGen Biopharmaceuticals Holdings Limited | 123.13 Million TWD | 96.061% |
OBI Pharma, Inc. | 41.54 Million TWD | 88.327% |
Meribank Biotech Co., Ltd | 234.34 Million TWD | 97.93% |
Acepodia, Inc. | 16.59 Million TWD | 70.771% |
Caliway Biopharmaceuticals Co., Ltd. | 38.93 Million TWD | 87.542% |